According to SIGAs statement in the WHO progress report on Dec 14th they will be licensed within a year.
33. The Advisory Committee also received updates from three pharmaceutical companies on
candidate vaccines and antiviral agents that are closest to licensure. Information presented included
data on efficacy, safety, stability and large-scale manufacturing capacity. The companies estimated
that they will be able to license their products, two antiviral agents and one candidate vaccine, within
Hey Ret, thanks for the post. Thinking back to Siga's Nov. conference call update I remember Rose responding to Greg Wade's question about future milestone payments, and the timing of the NDA. Rose said he expects the filing and approval of the NDA to occur after the completion of the delivery of courses to the SNS which they anticipate to take 24 months. After this comment he was quick to move on to the next topic before Wade could ask a follow-on question, letting him know that he couldn't provide any more insight on that timing. This seems pretty contradictory to the WHO comments, however his tone did fall in line with previous defensive posturing aimed at keeping PIP in the dark on anything related to 246 revs.
Welllllll, first of all, thanks for that Ret. Secondly, I find it interesting that we hear an update on SIGAs product licensing (by the way, that’s the same as registration, approval, marketing authorization, etc) from Ret on a WHO report!?!?! Finally, whoopty do, we here SIGA believes ST-246 will be approved in “within one year”. What, did people think we’d go into 2014 w/o approval?
Since the company doesn't provide any updates I think it's relevant what they are telling other sources. Yes. The other company is Chimerix of course. What have you posted of relevance lately you bag of sarcastic bag of wind?